Study Links Cannabis and Other Drugs to Increased Stroke Risk
Researchers at the University of Cambridge have conducted a significant study revealing that cannabis, cocaine, and amphetamines are linked to a notably higher risk of stroke, including among younger populations. This analysis draws on data from over 100 million individuals, making it one of the largest of its kind. Stroke is a major global health issue, ranking as the third leading cause of death and disability. While many risk factors for stroke can be modified through lifestyle changes, the role of recreational drug use has been less clear until now.
In 2024, it was reported that 8.8% of adults aged 16 to 59 in England and Wales, approximately 2.9 million individuals, had used a legal or illegal recreational drug in the past year. In the U.S., more than half of people over the age of 12 have reported using substances such as cocaine, cannabis, and opiates at least once in their lives. This widespread use raises concerns about the potential health implications, particularly regarding stroke risk.
The researchers aimed to clarify the connection between recreational drugs and stroke risk, as previous studies have produced mixed results. To achieve this, they performed a meta-analysis, which combines data from multiple cohort studies to draw more robust conclusions. Their findings, published in the International Journal of Stroke, indicate that cocaine and amphetamines are associated with nearly double the risk of stroke, with cocaine increasing the risk by 96% and amphetamines by 122%. Cannabis use was linked to a 37% increase in stroke risk. Interestingly, opioid use did not show a statistically significant association with stroke risk.
The study also focused on individuals under the age of 55, revealing that amphetamine use was associated with an alarming 174% increase in stroke risk, while cannabis and cocaine were linked to increases of 14% and 97%, respectively. This highlights the particularly high risk for younger users of these substances.
To further investigate these associations, the researchers employed Mendelian randomization, a method that uses genetic variants to assess causal relationships. This analysis indicated that cocaine use disorders were particularly associated with brain hemorrhage and cardioembolic stroke, while cannabis use disorders were linked to overall stroke risk, especially large artery strokes. The findings suggest a causal relationship rather than mere correlation, emphasizing the need for public health initiatives to address substance abuse as a means of reducing stroke risk.
Dr. Megan Ritson from the Stroke Research Group at the University of Cambridge stated, "This is the most comprehensive analysis ever conducted on recreational drug use and stroke risk and provides compelling evidence that drugs like cocaine, amphetamines, and cannabis are causal risk factors for stroke." Dr. Eric Harshfield, an Alzheimer's Society Research Fellow, added that the analysis suggests these drugs themselves increase stroke risk, rather than just reflecting other lifestyle factors among users. This underscores the importance of public health measures aimed at reducing substance abuse to help mitigate stroke risk.
The study received funding from the British Heart Foundation, along with support from the National Institute for Health and Care Research Cambridge Biomedical Research Center. The implications of this research are significant, as they provide a clearer understanding of how recreational drug use can impact health outcomes, particularly concerning stroke risk.




